Finance

Lists
4AB:FRA
AbbVie Common Stock
264,90 €
-1,08%
(-2,90) 1D
13 ნოე, 22:00:00 GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 4AB...
Open
267,20 €
High
269,00 €
Low
264,90 €
Mkt. cap
521,50 მლრ.
Avg. vol.
99,00
Volume
101,00
52-wk high
272,30 €
52-wk low
167,55 €
No. of employees
57 ათ.
Open
267,20 €
High
269,00 €
Low
264,90 €
Mkt. cap
521,50 მლრ.
Avg. vol.
99,00
Volume
101,00
52-wk high
272,30 €
52-wk low
167,55 €
No. of employees
57 ათ.
News stories
From web sources and news partners
Trefis
Trefis
·
1 დღის წინ
Is AbbVie Stock Really Expensive?
NewsBreak: Local News & Alerts
NewsBreak: Local News & Alerts
·
1 დღის წინ
3 Pharmaceutical Stocks That Offer Safety and Growth
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues. The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEOრობერ ეი მაიკლ
Employees57 ათ.
Founded10 აპრ. 2012
HeadquartersNorth Chicago, ილინოისი, ამერიკის შეერთებული შტატები
SectorHealth Care
Industry-
Websiteabbvie.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
დეკ. 2025
მარ. 2026
ივნ. 2026
სექ. 2026
Revenue
16,62 მლრდ.
15,00 მლრდ.
16,99 მლრდ.
17,40 მლრდ.
Cost of goods sold
4,55 მლრდ.
4,22 მლრდ.
4,29 მლრდ.
4,28 მლრდ.
Cost of revenue
4,55 მლრდ.
4,22 მლრდ.
4,29 მლრდ.
4,28 მლრდ.
Research and development expenses
2,58 მლრდ.
2,47 მლრდ.
2,34 მლრდ.
2,45 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,82 მლრდ.
3,49 მლრდ.
3,55 მლრდ.
3,80 მლრდ.
Operating expense
6,40 მლრდ.
5,96 მლრდ.
5,90 მლრდ.
6,23 მლრდ.
Total operating expenses
10,95 მლრდ.
10,18 მლრდ.
10,19 მლრდ.
10,51 მლრდ.
Operating income
5,67 მლრდ.
4,82 მლრდ.
6,80 მლრდ.
6,89 მლრდ.
Other non operating income
120,00 მლნ.
-3,00 მლნ.
-55,00 მლნ.
37,00 მლნ.
EBT including unusual items
2,67 მლრდ.
1,04 მლრდ.
4,28 მლრდ.
4,83 მლრდ.
EBT excluding unusual items
5,12 მლრდ.
4,19 მლრდ.
6,07 მლრდ.
6,19 მლრდ.
Income tax expense
853,00 მლნ.
342,00 მლნ.
662,00 მლნ.
609,00 მლნ.
Effective tax rate
31,97%
32,92%
15,47%
12,61%
Other operating expenses
-
-
-
-18,00 მლნ.
Net income
1,82 მლრდ.
695,00 მლნ.
3,61 მლრდ.
4,22 მლრდ.
Net profit margin
10,93%
4,63%
21,27%
24,24%
Earnings per share
2,71
2,65
3,65
3,82
Interest and investment income
59,00 მლნ.
72,00 მლნ.
67,00 მლნ.
102,00 მლნ.
Interest expense
-714,00 მლნ.
-717,00 მლნ.
-746,00 მლნ.
-802,00 მლნ.
Net interest expenses
-655,00 მლნ.
-645,00 მლნ.
-679,00 მლნ.
-700,00 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
7,66 მლრდ.
6,76 მლრდ.
8,68 მლრდ.
8,75 მლრდ.
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google აპები